XLPharmacy provides FREE EXPRESS Shipping on orders over $250.00  (Advertisement)
Please Visit Our Sister Site: The Hormone Shop.com

Subscribe to our 
Newsletter. Free!

 
Subscribe
Unsubscribe

Home 

Aclepsa Drug List 
Antibiotics
Bone Density Dictionary
Cipla,Products from 
Cipla,History of 
Compare Products  
FDA in India
Generics, History of
Glossary  
Pharmaceuticals
Safety of Indian Drugs  

Searches  
  National Library
  National Health
  Search This Site

XlPharmacy List

Mens Health 

Cialis™ 
Generic =
Tadalafil Citrate

Viagra™ 
Generic =
Sildenafil Citrate
 

Levitra™
Generic =
Vardenafil Citrate

Propecia™
Generic =
Finasteride

Cholesterol

Zocor™
Generic =

Simvastian

Lipitor™
Generic =

Atorvastatin

Pain Relief 

Ultram™
Generic =
Tramadol

Anti-Biotics

Amoxicillin
Generic =
Amoxil

Weight Loss

Acomplia™
Generic =
Rimonabant

Xenical™
Generic =
Orlistat

Anti-Depressants

Prozac™
Generic =
Fluoxetine

Paxil™
Generic
Paroxetine HCL

Digestive

Prevacid 
Lansoprazole

 

The FDA in India

FDA’s goals in India are to obtain better and more robust information to help FDA officials in the various FDA headquarter Offices and Centers and at the borders make better decisions about the products from India that are being developed for the U.S. market. This includes products that are being reviewed for marketing authorization in the USA, and that are presently already on the U.S. market. To this end, FDA activities in India include:

bulletEngaging with our Indian counterpart regulatory authorities to ensure the timely exchange and communication of information regarding clinical trials that are conducted, and the manufacturing of and transport of products from India, that are destined for the USA; 
bulletPartnering with our Indian counterpart agencies on various bilateral and regional capacity-building initiatives; 
bulletWorking with the regulated-product industries in India that wish to export their products to the USA to assure their understanding of our standards and expectations regarding FDA-regulated products; 
bulletCoordinating and collaborating on a daily basis on product quality and safety issues with other U.S. government agencies overseas that have complementary missions to our own (e.g., Department of Agriculture (USDA), Department of Homeland Security’s Customs and Border Protection (CBP), Department of Justice, Department of Commerce’s Foreign Commercial Service (FCS), the U.S. Trade Representative (USTR), Department of State, as well as other Department of Health and Human Service entities – Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH)); 
bulletAssessing, in real time and in-country, conditions and events in those areas that might have an impact on the safety and quality of FDA-regulated products exported to the USA from India; and 
bulletGathering better information about the clinical trial data conducted in India that support marketing applications in the USA and the manufacture of FDA-regulated products destined for the USA through increased capacity for more direct FDA inspections of relevant high-risk facilities and by working with private- and public-sector entities that wish to engage with FDA on third-party certification efforts regarding these products.
bulletThe India Office engages proactively and consistently with Indian regulatory counterparts and industry representatives to better accomplish FDA’s domestic mission to assure the safety, efficacy, and quality of FDA-regulated products. This includes managing the sharing of information and addressing regulatory compliance issues, some of which have a global impact. FDA’s communication with its foreign regulatory counterparts allows it to share technical expertise that enhances the country’s ability to produce safe foods and quality medical products. These information sharing and capacity building activities strengthen the ability of India to provide exports that meet the FDA standard and allow FDA to fulfill its mandate of consumer protection for Americans. 

| Back to Top |

bulletFDA Offices in India

The India Office also will allow the agency to:
bulletBuild or further strengthen a trusted regulator-to-regulator relationship with Government of India; 
bulletLearn more about the industries and challenges of how products are regulated in India; 
bulletMore easily inspect manufacturing and processing facilities in India that are producing products destined for the USA or determine how FDA can further leverage inspections already performed by its counterparts in India; 
bulletHave increased interactions with Indian manufacturers to help ensure that products shipped to the United States meet FDA standards for safety and manufacturing quality; 
bulletVerify that imported products and the way they are manufactured meet U.S. health and safety requirements.

When fully staffed, FDA will have 12 Staff in India; seven in New Delhi and 5 in Mumbai. Those in New Delhi are based in the U.S. Embassy and include a Director and six senior technical experts covering medicines, foods and devices. The inspectors in Mumbai are based at the U.S. Consulate General and are Consumer Safety Officers with expertise in these same regulated-product areas.

| Back to Top |

 

Sponsored Links

Please visit our Price Matching 
Aclepsa.com

Generic Viagra
$1.16/pill

Generic Cialis
$1.66/pill

Generic Levitra
$2.00/pill

Generic Propecia
$1.66/pill

Generic Acomplia
$1.66/pill

Sponsored Links

10% Discount Code
"TheHormoneShop"
at
4rX.com Pharmacy

Generic Viagra
$1.16/pill

Generic Cialis
$1.66/pill

Generic Levitra
$2.00/pill

Generic Propecia
$1.66/pill

Generic Acomplia
$1.66/pill

www.4rx.com

En Espanol

 

© 1998-2009 by Compare Generics

Norman@thehormoneshop.com
This page was last updated on 01/30/10

Please note that the sale of DHEA or Melatonin is not available, legally in Australia or any member nations of the
European Union (excluding the United Kingdom & Switzerland). Customers must  have a valid prescription in order to purchase
these products in Australia or any member nations of the European Union (excluding the United Kingdom & Switzerland)

Disclaimer: The Hormone Shop LLC assumes no liability, whether under a theory of contract, tort, negligence, product liability or otherwise. In no event shall The Hormone Shop LLC be liable for any direct or indirect, consequential, incidental, special, punitive or exemplary damages, or for any loss incurred due to results or comments that are reported or the use of collection materials that are supplied, or any prescriptions regardless of whether The Hormone Shop LLC knew or should have known of the possibility of such damages. Furthermore, in no event  shall The Hormone Shop LLC's total cumulative liability exceed The Hormone Shop LLC's net profit on any specific product, sample or  consultation giving rise to the liability.  The Hormone Shop LLC specifically assumes no liability incurred by any 3rd party associate and if you are reading this web site in a language other that English it has been machine translated by SYSTRAN who strives to achieve the highest possible accuracy, however no automated translation is perfect nor is it intended to replace human translators. Users should note that the quality of the source text significantly affects the translations and The Hormone Shop LLC assumes no liability for incorrect or misleading translations.  The questions and comments appearing in the "Discussion Group Forum" are strictly from unknown or unidentified sources and the reader/participant should be aware that credentials from any source are completely lacking and should be questioned.  The Hormone Shop LLC specifically assumes no liability for any comment or advice appearing in the "Discussion Forum".

These statements have not been evaluated by the Food & Drug
Administration. These products are not intended to diagnose, cure, treat or prevent
any disease. If pregnant or lactating, consult a physician before using.

Notice: This information  is provided for educational and nutritional purposes only. Any medical procedures, dietary changes or the use of dietary supplements discussed herein should only be undertaken on the advice of a qualified medical doctor. Although some are listed and sold as dietary supplements they are not innocuous, inert substances; rather they can and do affect vital systems within the human body and it is for this reason that you are urged to find a medical doctor who will work with you in monitoring and maintaining your well being.

These sites are the design work of Norman Rose who can be reached at norman@thehormoneshop.com 

http://thehormoneshop.com
http://www.drugsfromindia.net
http://www.ginkgo-inc.com
http://www.kc-real-estate.com
http://www.cybernetrealty.net
http://www.thehormoneshop.net 
http://www.thehormoneshop.org 
http://www.thehormoneshop.biz 
http://www.thehormoneshop.us 
http://www.flora-balance.com
http://www.genericsince1935.com
http://www.genericsince1998.com
http://www.genericsinspanish.com

http://www.indiagenerics.org